A Study of Momelotinib Versus Danazol in Symptomatic and Anemic Myelofibrosis Participants (MOMENTUM)

Clinical trial NCT04173494 · COMPLETED

Trial details

NCT number: NCT04173494
Sponsor: Sierra Oncology LLC - a GSK company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Myelofibrosis Post-polycythemia Vera Myelofibrosis Post-essential Thrombocythemia Myelofibrosis

Start date: 2020-02-07
Primary completion: 2021-12-03
Enrollment: 195

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.